Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer Patients.
Hilmi KodazBulent ErdoganIlhan HacibekirogluEsma TurkmenHilmi TozkirDogan AlbayrakSernaz UzunogluIrfan CicinPublished in: Hepato-gastroenterology (2016)
Primary tumor resection offers survival advantage in KRAS mutant patients, but randomized prospective studies are required.